1. Akintoye, D. O., Chebli, C., Booher, S., et al. (2002). Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. Journal of Clinical Endocrinology and Metabolism, 87, 5104–5112.
2. Albright, F., Butler, A. M., & Hampton, A. O. (1937). Syndrome characterized by osteitis fibrosa disseminate, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. The New England Journal of Medicine, 216, 727–747.
3. Anand, M. K. N. (2011). Fibrous dysplasia imaging. Medscape Reference. Updated 25 May 2011. Available at:
http://emedicine.medscape.com/article/389714-overview
4. Anitha, N., Leena Sankari, S., Malathi, L., et al. (2015). Fibrous dysplasia-recent concepts. Journal of Pharmacy and Bioallied Sciences, 7(Suppl 1), S171–S172.
5. Bareille, P., Azcona, C., & Stanhope, R. (1999). Multiple neonatal endocrinopathies in McCune-Albright syndrome. Journal of Paediatrics and Child Health, 35, 315–318.